Table 9. Blood Investigations on the 14th Day of the Studya.
| blood investigation parameters | group 1 (normal control) (mean ± SEM) | group 2 (negative control) (mean ± SEM) | group 3 (standard) (mean ± SEM) | group 4 (test-1) (mean ± SEM) | group 5 (test-2) (mean ± SEM) |
|---|---|---|---|---|---|
| WBC count (103/mm3) | 5.43 ± 0.209 | 2.86 ± 0.102 | 6.18 ± 0.254 | 4.45 ± 0.192 | 4.0 ± 0.131 |
| RBC (106/mm3) | 5.14 ± 0.103 | 2.57 ± 0.121 | 6.42 ± 0.042 | 5.13 ± 0.039 | 4.95 ± 0.048 |
| HGB (g/dLl) | 14.6 ± 0.167 | 8.3 ± 0.369 | 16.7 ± 0.278 | 14.0 ± 0.185 | 14.4 ± 0.269 |
| platelet count (103/mm3) | 458.3 ± 5.314 | 219.3 ± 7.342 | 517.5 ± 5.977 | 546.5 ± 4.681 | 527 ± 5.174 |
| neutrophil count (%) | 43.76 ± 2.736 | 15.45 ± 0.289 | 41.59 ± 3.448 | 31.02 ± 2.182 | 28.78 ± 1.227 |
| lymphocyte count (%) | 67.23 ± 2.527 | 32.73 ± 1.960 | 57.28 ± 2.002 | 50.63 ± 3.998 | 52.45 ± 1.502 |
| monocyte count (%) | 7.9 ± 0.129 | 3.01 ± 0.162 | 6.8 ± 0.279 | 6.9 ± 0.102 | 6.6 ± 0.235 |
| eosinophil count (%) | 4.8 ± 0.311 | 2.01 ± 0.116 | 3.73 ± 0.111 | 4.21 ± 0.262 | 3.78 ± 0.130 |
| basophil count (%) | 0.6 ± 0.05 | 0.3 ± 0.030 | 0.7 ± 0.077 | 0.5 ± 0.087 | 0.6 ± 0.05 |
a
ANOVA (singe factor), p>0.005 (p=0.973, f=0.123).